We aim to create an inspiring environment in which outstanding scientists can excel. By providing state-of-the-art core facilities and support for our researchers, we foster new collaborations that spark discoveries about fundamental cellular processes and their relevance in disease.
Annexin A2 is a novel mTOR-independent modulator of autophagy, reports the Rubinsztein lab in Nature Communications. Transcriptional upregulation of this actin-nucleating factor is important for actin-mediated sorting of ATG9A during autophagosome formation.
In Cell Reports, the Nathan lab show that the proteasome can distinguish between atypical ubiquitin chains of distinct topology. Whereas the proteasome can bind and degrade heterotypic lysine-11-linked chains, it cannot bind significantly to homotypic lysine-11-linked chains.
The first Young Investigator Meeting (YIM) UK will take place on the Cambridge Biomedical Campus on September 9th. Co-organized by early
career CIMR researchers and IndiaBioscience, this open meeting aims to promote networking among young scientists as well as new
Congratulations to Janet Deane, who is among 20 female researchers selected for the SUSTAIN programme. Run by the Academy of Medical Sciences, this scheme aims to help more women achieve senior positions.
The Guardian outlines the discovery by Geoff Woods that PRDM12 mutation can result in congenital insensitivity to pain (CIP) and the implications this may have in the longer term for development of new pain relief methods.